Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System
|
By LabMedica International staff writers Posted on 17 Apr 2014 |
|
The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable insights that transform how laboratories manage their business and their contributions to improving healthcare. It is used in optimizing the way laboratories, radiology groups, and health systems manage their provider and patient experience across the continuum of care. A winner of the 2013 Red Herring Top 100 Global award, hc1.com is in use worldwide across 500 healthcare locations.
This hc1.com software solution helps laboratories gain real-time visibility into key metrics, including test turnaround time (TAT), test utilization by provider, and productivity per lab operator. Additionally, the solution helps to identify important issues that require immediate action, as well as alert laboratory management to issues that are most prevalent across the entire health system
The partnership creates a powerful solution for clinical laboratories by combining hc1.com’s Software-as-a-Service Healthcare Relationship Cloud with Beckman Coulter’s clinical diagnostic systems. Beckman Coulter will offer hc1.com as its exclusive healthcare relationship management solution to help laboratories in North America manage their critical business and healthcare needs more proactively and with greater intelligence.
“The partnership between Beckman Coulter and hc1.com combines two highly complementary innovators to create value that can revolutionize the healthcare industry,” said Brad Bostic, chairman and CEO, hc1.com; “The agreement will allow Beckman Coulter’s customers to transform the healthcare experience by immediately addressing important provider needs, taking action on those needs, and ultimately delivering an amazing healthcare experience to patients and providers.”
“By leveraging hc1.com’s powerful software cloud solution, laboratories will be able to utilize and interpret more data than ever before to deliver a high level of performance to patients and providers,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “Innovative solutions and offerings such as these demonstrate our strong commitment to helping laboratories address challenges while maintaining focus on improving patient outcomes.”
Related Links:
Beckman Coulter Diagnostics
hc1.com
This hc1.com software solution helps laboratories gain real-time visibility into key metrics, including test turnaround time (TAT), test utilization by provider, and productivity per lab operator. Additionally, the solution helps to identify important issues that require immediate action, as well as alert laboratory management to issues that are most prevalent across the entire health system
The partnership creates a powerful solution for clinical laboratories by combining hc1.com’s Software-as-a-Service Healthcare Relationship Cloud with Beckman Coulter’s clinical diagnostic systems. Beckman Coulter will offer hc1.com as its exclusive healthcare relationship management solution to help laboratories in North America manage their critical business and healthcare needs more proactively and with greater intelligence.
“The partnership between Beckman Coulter and hc1.com combines two highly complementary innovators to create value that can revolutionize the healthcare industry,” said Brad Bostic, chairman and CEO, hc1.com; “The agreement will allow Beckman Coulter’s customers to transform the healthcare experience by immediately addressing important provider needs, taking action on those needs, and ultimately delivering an amazing healthcare experience to patients and providers.”
“By leveraging hc1.com’s powerful software cloud solution, laboratories will be able to utilize and interpret more data than ever before to deliver a high level of performance to patients and providers,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “Innovative solutions and offerings such as these demonstrate our strong commitment to helping laboratories address challenges while maintaining focus on improving patient outcomes.”
Related Links:
Beckman Coulter Diagnostics
hc1.com
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Latest Industry News
- Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
Channels
Clinical Chemistry
view channel
New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel_2.jpeg "Image: Microscopic view of the HPV human papillomavirus that causes cervical cancer (credit: Adobe Stock Images)")
New Molecular Test Detects More Cervical Cancer Cases
Cervical cancer screening is crucial for early detection and prevention. Many countries have comprehensive screening programs that begin with testing for various types of human papillomavirus (HPV), the... Read more
New Panel Quickly and Accurately Identifies 16 Common Gastrointestinal Pathogens
Gastrointestinal (GI) infections significantly contribute to infectious disease cases globally, particularly among young children. The symptoms of GI infections, such as diarrhea, nausea, vomiting, and... Read more
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel.jpg "Image: The AI tool predicts whether someone’s cancer will respond to immune checkpoint inhibitors (Photo courtesy of National Cancer Institute)")
AI Tool Predicts Cancer Patients’ Response to Immunotherapy
Immune checkpoint inhibitors are a form of immunotherapy drug that enables immune cells to target and destroy cancer cells. At present, the Food and Drug Administration has approved two predictive biomarkers... Read more
Molecular Profiling Improves Diagnosis for Children with High Risk Cancers
Cancer remains the leading cause of disease-related death among children in most developed nations, and approximately one-fourth of these patients are diagnosed with aggressive, high-risk, or relapsed... Read more
.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
Microbiology
view channel
POC STI Test Shortens Time from ED Arrival to Test Results
In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read morePathology
view channel
AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time
Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more
New Tool Enables Better Classification of Inherited Disease-Causing Variants
Whole genome and exome sequencing are increasingly available for clinical research, aiding in the detection of inherited genetic variants that may cause various diseases. The American College of Medical... Read more
Groundbreaking CRISPR Screen Technology Rapidly Determines Disease Mechanism from Tissues
Thanks to over a decade of advancements in human genetics, scientists have compiled extensive lists of genetic variations linked to a wide array of human diseases. However, understanding how a gene contributes... Read more
Technology
view channel
Microneedle Patch Detects Skin Cancer Early
Wearable bioelectronics has emerged as a significant innovation in healthcare, especially in the field of biosensing, providing a new method to monitor individual health for both diagnostic and therapeutic purposes.... Read more
